Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Cash from Investing Activities: 2021-2022

Historic Cash from Investing Activities for Cardiol Therapeutics (CRDL) over the last 1 years, with Sep 2022 value amounting to -$7,122.

  • Cardiol Therapeutics' Cash from Investing Activities fell 224.75% to -$7,122 in Q3 2022 from the same period last year, while for Sep 2022 it was -$15,290, marking a year-over-year change of. This contributed to the annual value of -$15,550 for FY2024, which is 67.38% up from last year.
  • As of Q3 2022, Cardiol Therapeutics' Cash from Investing Activities stood at -$7,122, which was down 326.68% from -$1,669 recorded in Q2 2022.
  • Over the past 5 years, Cardiol Therapeutics' Cash from Investing Activities peaked at $5,709 during Q3 2021, and registered a low of -$12,208 during Q1 2022.
  • Its 2-year average for Cash from Investing Activities is -$3,822, with a median of -$4,395 in 2022.
  • Data for Cardiol Therapeutics' Cash from Investing Activities shows a maximum YoY crashed of 224.75% (in 2022) over the last 5 years.
  • Quarterly analysis of 2 years shows Cardiol Therapeutics' Cash from Investing Activities stood at $5,709 in 2021, then tumbled by 224.75% to -$7,122 in 2022.
  • Its last three reported values are -$7,122 in Q3 2022, -$1,669 for Q2 2022, and -$12,208 during Q1 2022.